(NASDAQ: IRTC) Irhythm Technologies's forecast annual revenue growth rate of 15.69% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.68%.
Irhythm Technologies's revenue in 2025 is $591,839,000.On average, 5 Wall Street analysts forecast IRTC's revenue for 2025 to be $21,398,775,279, with the lowest IRTC revenue forecast at $21,365,449,676, and the highest IRTC revenue forecast at $21,482,607,547. On average, 4 Wall Street analysts forecast IRTC's revenue for 2026 to be $24,861,905,421, with the lowest IRTC revenue forecast at $24,493,219,337, and the highest IRTC revenue forecast at $25,215,012,335.
In 2027, IRTC is forecast to generate $28,390,084,879 in revenue, with the lowest revenue forecast at $28,242,271,222 and the highest revenue forecast at $28,537,929,947.